Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.5% versus 0.05% for prevention of myopia progression in Dutch children
2021-004015-11Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jul 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atropine in myopia (2 arms), sponsored by Erasmus MC. Primary endpoints: Axial length progression at Month 36 and Axial length progression at Month 60. Started Jul 2022; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2021-004015-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004015-11.